Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, Ikeda S
J Cardiogr. 1985 Mar;15(1):163-80.
To assess the clinical significance of technetium-99m-pyrophosphate (Tc-99m-PYP), -methylene diphosphonate (Tc-99m-MDP) and thallium-201 (Tl-201) myocardial scintigraphy in the diagnosis of cardiac amyloidosis and in the differential diagnosis of cardiac diseases, 12 patients with biopsy-proved systemic amyloidosis (seven with familial amyloid polyneuropathy (FAP) and five with primary amyloidosis) were investigated. The results obtained were as follows: In 10 patients (six with FAP and four with primary amyloidosis) studied by Tc-99m-PYP scintigraphy, two (FAP one, primary amyloidosis one) had diffusely positive myocardial uptake, which was of greater intensity than that of the sternum. Six (four FAP; two primary amyloidosis) also had diffusely positive myocardial uptakes, but the intensity was less than that of the sternum. The remaining two (one FAP; one primary amyloidosis) had only equivocal myocardial uptakes. Two of these patients also had hepatic uptakes and another had both hepatic and thyroid uptakes. The intensity of myocardial uptake of Tc-99m-PYP in patients with echocardiographic left ventricular hypertrophy and/or highly refractile myocardial echoes, so-called granular sparkling appearance (GS) was slightly greater than that in patients with neither myocardial hypertrophy nor GS. FAP had slightly less intensity than primary amyloidosis. In 29 persons with other cardiac diseases and normal subjects examined by Tc-99m-PYP scintigraphy, seven (two dilated cardiomyopathy; two sarcoidosis; three hypertensive heart disease) also had diffusely positive myocardial scans of mild or moderate degree. However, none of them had marked myocardial or other tissue uptakes. Both Tc-99m-PYP and -MDP scintigraphic studies were performed in four patients (three FAP; one primary amyloidosis). In Tc-99m-MDP scintigraphy, diffusely positive myocardial uptakes were observed in two patients with FAP and the remaining two had negative scans. The intensity of Tc-99m-MDP myocardial uptake in each patient was significantly lower than that of Tc-99m-PYP uptake. Tl-201 scintigraphy was carried out in 10 patients (six FAP; four primary amyloidosis). Left ventricular hypertrophy was found in six patients and right ventricular visualization in five. Although electrocardiograms in seven of 10 patients showed QS patterns in the right to mid precordial leads, similar to that seen in antero-septal and extensive anterior myocardial infarctions, neither myocardial perfusion defect nor low uptake on Tl-201 images was detected in nine of them. The scintigrams in another one, which showed low uptake at the apical portion of the left ventricle, were considered normal.(ABSTRACT TRUNCATED AT 400 WORDS)
为了评估锝-99m焦磷酸盐(Tc-99m-PYP)、亚甲基二膦酸盐(Tc-99m-MDP)和铊-201(Tl-201)心肌闪烁显像在心脏淀粉样变性诊断及心脏疾病鉴别诊断中的临床意义,对12例经活检证实为系统性淀粉样变性的患者(7例为家族性淀粉样多神经病(FAP),5例为原发性淀粉样变性)进行了研究。结果如下:在10例接受Tc-99m-PYP闪烁显像的患者(6例FAP,4例原发性淀粉样变性)中,2例(1例FAP,1例原发性淀粉样变性)心肌摄取呈弥漫性阳性,其强度大于胸骨。6例(4例FAP;2例原发性淀粉样变性)心肌摄取也呈弥漫性阳性,但强度低于胸骨。其余2例(1例FAP;1例原发性淀粉样变性)心肌摄取仅为可疑阳性。其中2例患者肝脏也有摄取,另1例肝脏和甲状腺均有摄取。超声心动图显示左心室肥厚和/或心肌回声高度增强(即所谓的颗粒状闪烁外观(GS))的患者,其Tc-99m-PYP心肌摄取强度略高于既无心肌肥厚也无GS的患者。FAP的强度略低于原发性淀粉样变性。在29例患有其他心脏疾病的患者和正常受试者中进行Tc-99m-PYP闪烁显像,7例(2例扩张型心肌病;2例结节病;3例高血压性心脏病)心肌扫描也呈弥漫性轻度或中度阳性。然而,他们均无明显的心肌或其他组织摄取。4例患者(3例FAP;1例原发性淀粉样变性)同时进行了Tc-99m-PYP和-MDP闪烁显像研究。在Tc-99m-MDP闪烁显像中,2例FAP患者心肌摄取呈弥漫性阳性,其余2例扫描为阴性。每位患者的Tc-99m-MDP心肌摄取强度均显著低于Tc-99m-PYP摄取强度。对10例患者(6例FAP;4例原发性淀粉样变性)进行了Tl-201闪烁显像。6例患者发现左心室肥厚,5例右心室显影。尽管10例患者中有7例心电图在右胸前导联至中胸前导联显示QS波型,类似于前间壁和广泛前壁心肌梗死所见,但其中9例在Tl-201图像上未检测到心肌灌注缺损或摄取减低。另一例患者左心室心尖部摄取减低,其闪烁显像被认为正常。(摘要截取自400字)